IUPAC/Chemical Name
Ajmalanium, 17,21-dihydroxy-4-propyl-, (17R,21-alpha)-
InChi Key
UAUHEPXILIZYCU-ALHOSYKFSA-N
InChi Code
InChI=1S/C23H33N2O2/c1-4-10-25-17-11-14(13(5-2)22(25)27)19-18(25)12-23(21(19)26)15-8-6-7-9-16(15)24(3)20(17)23/h6-9,13-14,17-22,26-27H,4-5,10-12H2,1-3H3/q+1/t13-,14-,17-,18-,19-,20-,21+,22+,23+,25-/m0/s1
SMILES Code
CCC[N@+]12[C@@H]([C@H]([C@@H]3C[C@H]1[C@@H]4N(c5c([C@]46C[C@H]2[C@H]3[C@H]6O)cccc5)C)CC)O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
369.53
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Piekarska A. [Cholestatic hepatitis caused by prajmalium treatment: case report]. Pol Arch Med Wewn. 2003 Jun;109(6):629-32. Polish. PubMed PMID: 14567096.
2: Fischer S, Reinhold S, Kettner W. [Brugada syndrome]. Med Klin (Munich). 2001 Aug 15;96(8):485-8. German. PubMed PMID: 11560050.
3: Almási R, Mágel F, Kósik G. [Cardiogenic shock and ventricular fibrillation induced by prajmalium and metoprolol poisoning]. Orv Hetil. 1996 Mar 31;137(13):695-700. Hungarian. PubMed PMID: 8649751.
4: Szufladowicz E, Walczak F, Kozluk E, Jedynak Z, Buszman P, Lastowiecka E, Stepińska J. [Difficulties with pharmacologic treatment of a patient with atrioventricular nodal reentrant tachycardia]. Kardiol Pol. 1993 Oct;39(10):285-7. Polish. PubMed PMID: 8246357.
5: Lenzen R, Stremmel W, Strohmeyer G. Antiarrhythmic drugs impair hepatic uptake and secretory function by different mechanisms in the isolated perfused rat liver. Biochim Biophys Acta. 1991 Aug 6;1074(3):406-12. PubMed PMID: 1888751.
6: Lenzen R, Gottesbüren H, Borchard F, Wienbeck M, Strohmeyer G. [Intrahepatic cholestasis and aplastic anemia following administration of prajmaline]. Klin Wochenschr. 1988 Mar 15;66(6):264-70. German. PubMed PMID: 2452916.
7: Jaeger M. [How should we treat the Wolff-Parkinson-White syndrome]. Rev Med Suisse Romande. 1986 Oct;106(10):927-32. French. PubMed PMID: 3787033.
8: Szatmáry L, Czakó E, Rényi-Vámos F, Bodor E, Rablóczky G. The acute effect of ajmaline on ventricular arrhythmia after cardiac surgery. Acta Med Hung. 1986;43(3):321-31. PubMed PMID: 3588171.
9: Schmidt G, Goedel-Meinen L, Jahns G, Linné R, Schaudig U, Kein G, Baedeker W, Wirtzfeld A. Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias. Drugs. 1985 Mar;29 Suppl 3:37-46. PubMed PMID: 3996244.
10: Rotmensch HH, Weintraub M, Sofferman G, Livni E, Klejman A, Liron M. Experience with immunological tests in drug-induced hepatitis. Z Gastroenterol. 1981 Nov;19(11):691-7. PubMed PMID: 7032097.
